MedPath

Chenodal

Chenodal

Approved
Approval ID

769e0a3b-826d-4faf-9129-5eeb7ebe0b67

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jul 12, 2023

Manufacturers
FDA

Travere Therapeutics

DUNS: 965454502

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Chenodiol

PRODUCT DETAILS

NDC Product Code68974-876
Application NumberANDA091019
Marketing CategoryC73584
Route of AdministrationORAL
Effective DateJuly 7, 2023
Generic NameChenodiol

INGREDIENTS (8)

SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4
Classification: IACT
SODIUM STARCH GLYCOLATE TYPE AInactive
Code: H8AV0SQX4D
Classification: IACT
MICROCRYSTALLINE CELLULOSEInactive
Code: OP1R32D61U
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
GLYCERINInactive
Code: PDC6A3C0OX
Classification: IACT
METHYLCELLULOSE (100 MPA.S)Inactive
Code: 4GFU244C4J
Classification: IACT
SODIUM LAURYL SULFATEInactive
Code: 368GB5141J
Classification: IACT
CHENODIOLActive
Quantity: 250 mg in 1 1
Code: 0GEI24LG0J
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.